15 results
8-K
TCRX
Tscan Therapeutics Inc
7 Dec 23
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
7:15am
the requirements for independence of Audit Committee members under the applicable listing standards of Nasdaq and the Securities Exchange Act of 1934, as amended
DEF 14A
ghuajlh9w 17ftya
21 Apr 22
Definitive proxy
8:00am
10-K
e0ey4 65n9f
9 Mar 22
Annual report
7:30am
8-K
EX-3.2
5wa2e5rj4bb1p12
20 Jul 21
Departure of Directors or Certain Officers
4:36pm
424B4
ozashd
19 Jul 21
Prospectus supplement with pricing info
7:01am
S-1/A
56nib71 07wzuggzxet5
30 Apr 21
IPO registration (amended)
5:00pm
S-1
EX-3.4
oykgw34
23 Apr 21
IPO registration
5:15pm
S-1
y77rki7x7h75 g9
23 Apr 21
IPO registration
5:15pm
DRS
ckppb0
19 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next